We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Obesity‐Associated Myeloid Immunosuppressive Cells, Key Players in Cancer Risk and Response to Immunotherapy.
- Authors
Sanchez‐Pino, Maria Dulfary; Gilmore, Linda Anne; Ochoa, Augusto C.; Brown, Justin C.
- Abstract
Obesity is a risk factor for developing several cancers. The dysfunctional metabolism and chronic activation of inflammatory pathways in obesity create a milieu that supports tumor initiation, progression, and metastasis. Obesity‐associated metabolic, endocrine, and inflammatory mediators, besides interacting with cells leading to a malignant transformation, also modify the intrinsic metabolic and functional characteristics of immune myeloid cells. Here, the evidence supporting the hypothesis that obesity metabolically primes and promotes the expansion of myeloid cells with immunosuppressive and pro‐oncogenic properties is discussed. In consequence, the accumulation of these cells, such as myeloid‐derived suppressor cells and some subtypes of adipose‐tissue macrophages, creates a microenvironment conducive to tumor development. In this review, the role of lipids, insulin, and leptin, which are dysregulated in obesity, is emphasized, as well as dietary nutrients in metabolic reprogramming of these myeloid cells. Moreover, emerging evidence indicating that obesity enhances immunotherapy response and hypothesized mechanisms are summarized. Priorities in deeper exploration involving the mechanisms of cross talk between metabolic disorders and myeloid cells related to cancer risk in patients with obesity are highlighted.
- Subjects
MYELOID cells; DISEASE risk factors; MYELOID-derived suppressor cells; METABOLIC disorders; CANCER cells; INFLAMMATORY mediators
- Publication
Obesity (19307381), 2021, Vol 29, Issue 6, p944
- ISSN
1930-7381
- Publication type
Article
- DOI
10.1002/oby.23108